Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191474 · ClinicalTrials.gov registry record · NA
Linkage of Transgender Individuals to PrEP
A NA study of HIV Seronegativity and Linkage, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
- 2
- Study locations
NCT03191474: Completed NA study of HIV Seronegativity and Linkage, sponsored by University of California, San Diego.
NCT03191474 is a NA study of HIV Seronegativity and Linkage that has completed, run by University of California, San Diego. The registered enrollment target is 202 participants, above the 109-participant average among 3 other HIV Seronegativity trials with a reported enrollment target (85% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03191474, a NA study of HIV Seronegativity and Linkage, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
- 2
- Study locations
Study Summary
CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).
Primary Outcome
To evaluate the effectiveness of a T-POWr intervention to effectively link transgender / gender non-conforming persons to a PrEP evaluation visit.
Conditions Studied
Interventions
- BEHAVIORAL T-POWr Intervention
Study Locations (2)
California
- Los Angeles Lesbian, Gay, Bisexual, and Transgender Center - Los Angeles
- UC San Diego AntiViral Research Center (AVRC) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2017-07-28 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
What the finished NCT03191474 record still lists
NCT03191474 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, above the 109-participant average among 3 other HIV Seronegativity trials with a reported enrollment target (85% higher).
The record links to 2 conditions, with HIV Seronegativity appearing as the primary indexed condition, and to 1 intervention - of which T-POWr Intervention is the first listed.
NCT03191474 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03191474 about?
NCT03191474 is a clinical study titled "Linkage of Transgender Individuals to PrEP". CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).
What is the current status of trial NCT03191474?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2017-07-28. Estimated completion is 2020-03-31.
What conditions does trial NCT03191474 study?
This clinical trial studies the following conditions: HIV Seronegativity, Linkage.
What interventions are being tested in trial NCT03191474?
The interventions under investigation include: T-POWr Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03191474?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03191474 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Seronegativity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI